BNP Paribas Financial Markets
ZBIO

BNP Paribas Financial Markets’s Zenas BioPharma ZBIO Stock Holding History

BNP Paribas Financial Markets’s Portfolio ZBIO Stock Details ZBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$195K Buy
9,999
+2,861
+40% +$64.2K ﹤0.01% 4066
2025
Q4 		$259K Buy
7,138
+3,992
+127% +$131K ﹤0.01% 3935
2025
Q3 		$69.8K Buy
3,146
+1,716
+120% +$27.9K ﹤0.01% 4452
2025
Q2 		$13.9K Sell
1,430
-23,868
-94% -$232K ﹤0.01% 4752
2025
Q1 		$200K Buy
25,298
+7,053
+39% +$55.2K ﹤0.01% 3700
2024
Q4 		$149K Buy
+18,245
New +$285K ﹤0.01% 4018

Other funds holding ZBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NA
NVP Associates Menlo Park, California $176M AUM 208.78% 1-Year Est. Return

BNP Paribas Financial Markets's ZBIO Position: Q1 2026 in Review

BNP Paribas Financial Markets increased its Zenas BioPharma (ZBIO) stake by 40% in Q1 2026, buying an estimated $64.2K and bringing the position to 9,999 shares worth $195K. The position accounts for ﹤0.01% of the portfolio, ranked #4066.

BNP Paribas Financial Markets first reported a position in ZBIO in Q4 2024 and has held it in 6 quarters since. The position peaked at $259K in Q4 2025. 139 funds tracked by Wall St. Rank hold ZBIO as of Q1 2026.

  • BNP Paribas Financial Markets held 9,999 shares of Zenas BioPharma worth $195K as of Q1 2026.
  • BNP Paribas Financial Markets bought 2,861 Zenas BioPharma shares in Q1 2026, an estimated $64.2K.
  • Zenas BioPharma made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q1 2026, its #4066 holding.
  • BNP Paribas Financial Markets first reported a position in Zenas BioPharma in Q4 2024 and has held it in 6 quarters since.
  • BNP Paribas Financial Markets's Zenas BioPharma position peaked at $259K in Q4 2025.
  • 139 funds tracked by Wall St. Rank held Zenas BioPharma as of Q1 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.